Press coverage about Kindred Healthcare (NYSE:KND) has trended somewhat positive recently, Accern Sentiment reports. The research firm rates the sentiment of news coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Kindred Healthcare earned a news impact score of 0.08 on Accern’s scale. Accern also assigned news articles about the health services provider an impact score of 45.8721916019227 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the immediate future.

Kindred Healthcare (NYSE KND) opened at $9.05 on Tuesday. The company has a quick ratio of 1.53, a current ratio of 1.55 and a debt-to-equity ratio of 6.22. The stock has a market capitalization of $786.74, a P/E ratio of -4.59 and a beta of 1.13. Kindred Healthcare has a fifty-two week low of $5.50 and a fifty-two week high of $11.90.

Kindred Healthcare (NYSE:KND) last announced its quarterly earnings results on Monday, November 6th. The health services provider reported ($0.11) earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of ($0.19) by $0.08. The firm had revenue of $1.48 billion during the quarter, compared to the consensus estimate of $1.44 billion. Kindred Healthcare had a positive return on equity of 2.29% and a negative net margin of 8.06%. The firm’s quarterly revenue was down 5.5% compared to the same quarter last year. During the same period in the prior year, the company posted $0.05 earnings per share. equities analysts anticipate that Kindred Healthcare will post 0.31 EPS for the current fiscal year.

A number of equities analysts have recently commented on KND shares. ValuEngine raised Kindred Healthcare from a “sell” rating to a “hold” rating in a research report on Thursday, November 9th. Zacks Investment Research raised Kindred Healthcare from a “hold” rating to a “buy” rating and set a $11.00 price objective for the company in a research report on Wednesday, January 10th. Stifel Nicolaus raised Kindred Healthcare from a “sell” rating to a “hold” rating and set a $7.00 price objective for the company in a research report on Monday, November 20th. Mizuho reissued a “neutral” rating and set a $7.50 price objective (down from $8.00) on shares of Kindred Healthcare in a research report on Tuesday, October 10th. Finally, Royal Bank of Canada reissued a “sector perform” rating and set a $8.50 price objective (up from $7.50) on shares of Kindred Healthcare in a research report on Thursday, November 9th. Two equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and one has issued a buy rating to the stock. The company has a consensus rating of “Hold” and an average price target of $9.31.

ILLEGAL ACTIVITY NOTICE: “Kindred Healthcare (KND) Getting Somewhat Positive News Coverage, Analysis Shows” was first reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this piece of content on another site, it was illegally stolen and reposted in violation of United States & international trademark & copyright legislation. The original version of this piece of content can be read at https://www.thecerbatgem.com/2018/02/06/kindred-healthcare-knd-getting-somewhat-positive-news-coverage-analysis-shows.html.

About Kindred Healthcare

Kindred Healthcare, Inc, incorporated on March 27, 1998, is a healthcare services company. The Company, through its subsidiaries, operates transitional care (TC) hospitals, a home health, hospice and community care business, inpatient rehabilitation hospitals (IRFs), a contract rehabilitation services business, nursing centers and assisted living facilities across the United States.

Insider Buying and Selling by Quarter for Kindred Healthcare (NYSE:KND)

Receive News & Ratings for Kindred Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kindred Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.